Literature DB >> 25046214

Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study.

M Kirsch1, A Götz2, J P Halter3, U Schanz2, G Stussi4, F Dobbels5, S De Geest6.   

Abstract

Little is known of health-relevant behaviour among long-term survivors of haematological disorders treated with haematopoietic SCT. This comparative cross-sectional multicentre study aimed (1) to explore the prevalence of selected behaviours in this group and (2) to compare them with those of the general population. Self-reported data of 376 survivors (mean age: 50.4 (s.d. = 12.8); median 7 years postallogeneic SCT (interquartile range (IQR) = 8.9; range 1-33) were compared with controls derived from the Swiss Health Survey 2007 by propensity score matching. Survivors were more physically inactive (26.8% vs 12.5%; P ⩽ 0.001) and consumed fewer portions of vegetables (⩾ 3 pieces: 10% vs 21.6%; P < 0.001), fruits (⩾ 3 pieces: 6.5% vs 10.6%; P < 0.001) and fish (31.2% vs 60.9% weekly fish dish; P < 0.001). More survivors consumed dairy products daily (92.5% vs 62.9%; P < 0.001), used sun protection regularly (94.5% vs 85.3%, P < 0.001) and had received influenza vaccinations in the past year (58.4% vs 21.5%; P < 0.001); fewer survivors smoked (13.4% vs 35.4%; P < 0.001). Survivors' weekly alcohol consumption was lower (median 1.5 servings (IQR 4) vs median 4.5 (IQR 10.3); P < 0.001). Of those taking immunosuppressants, 65.7% were non-adherent. Similar to the general population, survivors experience problems executing several health-enhancing behaviours, warranting corrective interventions.

Entities:  

Mesh:

Year:  2014        PMID: 25046214     DOI: 10.1038/bmt.2014.142

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  34 in total

1.  Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.

Authors:  Can-Lan Sun; Liton Francisco; Toana Kawashima; Wendy Leisenring; Leslie L Robison; K Scott Baker; Daniel J Weisdorf; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2010-07-23       Impact factor: 22.113

Review 2.  The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status.

Authors:  Sarah Connor Gorber; Sean Schofield-Hurwitz; Jill Hardt; Geneviève Levasseur; Mark Tremblay
Journal:  Nicotine Tob Res       Date:  2009-01-27       Impact factor: 4.244

3.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  N S Majhail; J D Rizzo; S J Lee; M Aljurf; Y Atsuta; C Bonfim; L J Burns; N Chaudhri; S Davies; S Okamoto; A Seber; G Socie; J Szer; M T Van Lint; J R Wingard; A Tichelli
Journal:  Bone Marrow Transplant       Date:  2012-03       Impact factor: 5.483

4.  Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls.

Authors:  Karen L Syrjala; Shelby L Langer; Janet R Abrams; Barry E Storer; Paul J Martin
Journal:  J Clin Oncol       Date:  2005-09-20       Impact factor: 44.544

5.  Ethnic differences in chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.

Authors:  Saro H Armenian; Can-Lan Sun; Jennifer Berano Teh; Mukta Arora; K Scott Baker; Liton Francisco; Stephen J Forman; Smita Bhatia
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

Review 6.  Gastrointestinal, hepatobiliary, pancreatic, and iron-related diseases in long-term survivors of allogeneic hematopoietic cell transplantation.

Authors:  Aiko Kida; George B McDonald
Journal:  Semin Hematol       Date:  2012-01       Impact factor: 3.851

7.  Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation.

Authors:  Eric J Chow; K Scott Baker; Stephanie J Lee; Mary E D Flowers; Kara L Cushing-Haugen; Yoshihiro Inamoto; Nandita Khera; Wendy M Leisenring; Karen L Syrjala; Paul J Martin
Journal:  J Clin Oncol       Date:  2013-12-02       Impact factor: 44.544

Review 8.  European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN.

Authors:  D Engelhard; B Mohty; R de la Camara; C Cordonnier; P Ljungman
Journal:  Transpl Infect Dis       Date:  2013-01-31       Impact factor: 2.228

Review 9.  Cardiovascular disease in survivors of hematopoietic cell transplantation.

Authors:  Saro H Armenian; Eric J Chow
Journal:  Cancer       Date:  2013-10-25       Impact factor: 6.860

10.  Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants.

Authors:  Elisa de Oliveira Marsicano; Neimar da Silva Fernandes; Fernando Colugnati; Fabiane Rossi dos Santos Grincenkov; Natalia Maria da Silva Fernandes; Sabina De Geest; Helady Sanders-Pinheiro
Journal:  BMC Nephrol       Date:  2013-05-21       Impact factor: 2.388

View more
  10 in total

1.  Medication nonadherence to immunosuppressants after adult allogeneic haematopoietic stem cell transplantation: a multicentre cross-sectional study.

Authors:  B Gresch; M Kirsch; K Fierz; J P Halter; G Nair; K Denhaerynck; S De Geest
Journal:  Bone Marrow Transplant       Date:  2016-11-14       Impact factor: 5.483

Review 2.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.

Authors:  Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-19       Impact factor: 5.742

3.  Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma.

Authors:  Solomon A Graf; Jennifer E Vaughn; Thomas R Chauncey; Barry E Storer; Ajay K Gopal; Leona A Holmberg; Jeannine S McCune; William I Bensinger; David G Maloney; Oliver W Press; Rainer Storb; Mohamed L Sorror
Journal:  Biol Blood Marrow Transplant       Date:  2016-06-14       Impact factor: 5.742

4.  Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers.

Authors:  Donna M Posluszny; Dana H Bovbjerg; Karen L Syrjala; Mounzer Agha; Rafic Farah; Jing-Zhou Hou; Anastasios Raptis; Annie P Im; Kathleen A Dorritie; Michael M Boyiadzis; Mary Amanda Dew
Journal:  Transplant Cell Ther       Date:  2021-12-04

5.  It Takes a Team to Make It Through: The Role of Social Support for Survival and Self-Care After Allogeneic Hematopoietic Stem Cell Transplant.

Authors:  Yaena Song; Stephanie Chen; Julia Roseman; Eileen Scigliano; William H Redd; Gertraud Stadler
Journal:  Front Psychol       Date:  2021-03-26

6.  Exploring Stem Cell Transplanted Patients' Perspectives on Medication Self-Management and Electronic Monitoring Devices Measuring Medication Adherence: A Qualitative Sub-Study of the Swiss SMILe Implementation Science Project.

Authors:  Janette Ribaut; Sabina De Geest; Lynn Leppla; Sabine Gerull; Alexandra Teynor; Sabine Valenta
Journal:  Patient Prefer Adherence       Date:  2022-01-06       Impact factor: 2.711

7.  The SMILe integrated care model in allogeneic SteM cell TransplantatIon faciLitated by eHealth: a protocol for a hybrid effectiveness-implementation randomised controlled trial.

Authors:  Sabina De Geest; Sabine Valenta; Lynn Leppla; Alexandra Teynor; Janette Ribaut; Sabine Gerull; Juliane Mielke; Michael Simon; Jana Bartakova; Klaus Kaier; Jens Eckstein
Journal:  BMC Health Serv Res       Date:  2022-08-20       Impact factor: 2.908

8.  Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health.

Authors:  Daniel Wolff; Philipp Y Herzberg; Anne Herrmann; Steven Z Pavletic; Pia Heussner; Friederike Mumm; Christina Höfer; Inken Hilgendorf; Philipp G Hemmati; Ernst Holler; Hildegard Greinix; Sandra A Mitchell
Journal:  Bone Marrow Transplant       Date:  2020-07-31       Impact factor: 5.483

9.  Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project.

Authors:  Janette Ribaut; Lynn Leppla; Alexandra Teynor; Sabine Valenta; Fabienne Dobbels; Leah L Zullig; Sabina De Geest
Journal:  BMC Health Serv Res       Date:  2020-09-02       Impact factor: 2.655

10.  Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth-the SMILe study.

Authors:  Lynn Leppla; Anja Schmid; Sabine Valenta; Juliane Mielke; Sonja Beckmann; Janette Ribaut; Alexandra Teynor; Fabienne Dobbels; Nathalie Duerinckx; Robert Zeiser; Monika Engelhardt; Sabine Gerull; Sabina De Geest
Journal:  Support Care Cancer       Date:  2021-07-05       Impact factor: 3.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.